Human papillomavirus testing in the prevention of cervical cancer
M Schiffman, N Wentzensen… - Journal of the …, 2011 - academic.oup.com
Strong evidence now supports the adoption of cervical cancer prevention strategies that
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …
[HTML][HTML] Interplay among vaginal microbiome, immune response and sexually transmitted viral infections
MG Torcia - International journal of molecular sciences, 2019 - mdpi.com
The vaginal ecosystem is important for women's health and for a successful reproductive life,
and an optimal host-microbial interaction is required for the maintenance of eubiosis. The …
and an optimal host-microbial interaction is required for the maintenance of eubiosis. The …
Human papillomavirus types in 115,789 HPV‐positive women: a meta‐analysis from cervical infection to cancer
P Guan, R Howell‐Jones, N Li, L Bruni… - … journal of cancer, 2012 - Wiley Online Library
Genotyping may improve risk stratification of high‐risk (HR) human papillomavirus (HPV)‐
positive women in cervical screening programs; however, prospective data comparing the …
positive women in cervical screening programs; however, prospective data comparing the …
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
N Li, S Franceschi, R Howell‐Jones… - … journal of cancer, 2011 - Wiley Online Library
Pooled data on human papillomavirus (HPV) type distribution in invasive cervical cancer
(ICC) can help to predict the potential impact of HPV type‐specific vaccines and screening …
(ICC) can help to predict the potential impact of HPV type‐specific vaccines and screening …
[HTML][HTML] Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women
P Łaniewski, D Barnes, A Goulder, H Cui, DJ Roe… - Scientific reports, 2018 - nature.com
While high-risk human papillomavirus (HPV) infection is a well-established risk factor for
cervical cancer, there are likely other factors within the local microenvironment that …
cervical cancer, there are likely other factors within the local microenvironment that …
[HTML][HTML] Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues
Human papilloma viruses (HPV) are a small group of non‑enveloped viruses belonging to
the Papillomaviridae family with strong similarities to polyoma viruses. The viral particles …
the Papillomaviridae family with strong similarities to polyoma viruses. The viral particles …
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: a meta‐analysis update
JS Smith, L Lindsay, B Hoots, J Keys… - … journal of cancer, 2007 - Wiley Online Library
Data on human papillomavirus (HPV) type distribution in invasive and pre‐invasive cervical
cancer is essential to predict the future impact of HPV16/18 vaccines and HPV‐based …
cancer is essential to predict the future impact of HPV16/18 vaccines and HPV‐based …
Molecular biology of human papillomavirus infection and cervical cancer
J Doorbar - Clinical science, 2006 - portlandpress.com
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging
from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types …
from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types …
[HTML][HTML] Evidence-based clinical guidelines for immigrants and refugees
Health: Deborah Assayag, Elizabeth Barnett, Jennifer Blake, Beverly Brockest, Giovani
Burgos, Glenn Campbell, Andrea Chambers, Angie Chan, Maryann Cheetham, Walter …
Burgos, Glenn Campbell, Andrea Chambers, Angie Chan, Maryann Cheetham, Walter …
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
JML Brotherton, M Fridman, CL May, G Chappell… - The Lancet, 2011 - thelancet.com
Background Australia introduced a human papillomavirus (HPV) vaccination programme
with the quadrivalent HPV vaccine for all women aged 12–26 years between 2007 and …
with the quadrivalent HPV vaccine for all women aged 12–26 years between 2007 and …